The source cabinet
GHK-Cu traces its origins to liver tissue
The story starts with aged liver tissue. Skin creams come later. Between them lies a surprisingly unruly history of copper, collagen and experiments worth returning to.
The liver experiment
The first surprise in GHK-Cu’s history is the organ: liver. The trail leads to human plasma and aged liver tissue. In 1973, Loren Pickart isolated GHK as a factor that prompted the tissue to make proteins more like younger tissue. That is a peculiar beginning for something now associated so closely with skin care.
The distinction matters to the story: the discovery concerned GHK, the peptide without copper attached. The copper complex later became a subject of wound-healing and skin-repair research. The tissue-remodeling literature describes a much broader set of experiments than the familiar wrinkle claim suggests.
For me, the liver detour supplies the reason to stay interested. A small molecule showing up in such different settings is an excellent biological puzzle. I distrust the leap from those scattered findings to a general promise of rejuvenation.
GHK-Cu synthesis and copper binding
GHK is a tripeptide, a chain of three amino acids: glycine, histidine and lysine. It occurs naturally in plasma, saliva and urine, and its sequence also appears within collagen. GHK-Cu pairs the peptide with copper in a 1:1 complex. Copper Tripeptide-1 is the cosmetic-ingredient name.
For GHK-Cu synthesis, the peptide sequence is only part of the identity. The copper-bound form has to be distinguished from free GHK. In a fibroblast-culture comparison, GHK-Cu stimulated MMP-2, an enzyme involved in remodeling the material around cells; free GHK did not reproduce that response. The copper attachment changes the experiment.
That is why the term GHK-Cu research peptide deserves some care. A paper about free GHK, a modified GHK molecule or a mixture can be interesting on its own terms. Each has its own starting material and its own result.
Collagen synthesis
The 1988 human fibroblast study is a good place to get specific. Fibroblasts are the cells that make much of skin’s supporting material. Adding GHK-Cu increased their collagen synthesis while cell numbers stayed steady. The cells were making more collagen apiece.
What wins me over here is the precision. It gives the result a clear location and a clear meaning: collagen production in cultured cells. The later skin-regeneration review also describes elastin, which gives tissue spring, and other components of the extracellular matrix, the supporting material outside cells.
The route from those dishes to a cream has another obstacle: skin itself. The copper peptide skin research follows both the collagen findings and the work on getting the compound through the outer barrier.
Blood levels and the anti-aging story
The 2015 review reports plasma GHK levels of approximately 200 ng/mL at age 20 and approximately 80 ng/mL by age 60. Those measurements give the aging hypothesis a starting point. They leave open the causal question: whether replacing a declining level would improve health.
My enthusiasm is greater for the concrete collagen result than for the broad anti-aging conclusion. The GHK-Cu research page follows the lung-cell, mouse-cell and hair experiments; copper peptide benefits takes up the gene-expression claims. Reported effects and safety covers the very different material that arrives as personal accounts.
GHK-Cu has no FDA- or EMA-approved therapeutic use. Its established real-world history is as a topical cosmetic ingredient; injectable and systemic uses remain unapproved. The published study amounts are collected under GHK-Cu dosage research.